ClinicalTrials.gov
public full text
Public Domain
Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
To investigate efficacy, safety and PK of GEM monotherapy after prior chemotherapy with anthracycline and taxane regimen for patients with metastatic breast cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer#1139099
- Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients#888373
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer#969681
- Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse#1112443
- Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer#902069
Record · ID 994263
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive